Disruption of de Novo Adenosine Triphosphate (ATP) Biosynthesis Abolishes Virulence in Cryptococcus neoformans

Area of Science:

• Mycology
• Biochemistry
• Structural Biology

Background:

• Opportunistic fungal infections, particularly Cryptococcus neoformans, pose a significant threat to immunocompromised individuals.
• There is an urgent need for novel antifungal agents due to limited therapeutic options and emerging resistance.
• Adenylosuccinate synthetase (AdSS) is vital for adenosine triphosphate (ATP) biosynthesis in fungi.

Purpose of the Study:

• To evaluate Adenylosuccinate synthetase (AdSS) as a potential antifungal drug target.
• To investigate the role of AdSS in the virulence and survival of Cryptococcus neoformans.
• To characterize the structural and kinetic properties of fungal AdSS for drug design.

Main Methods:

• Genetic manipulation to create a loss-of-function AdSS mutant in C. neoformans.
• Virulence assessment in a murine model.
• Expression and purification of Cryptococcal AdSS in E. coli.
• X-ray crystallography to determine the 3D structure of fungal AdSS.
• Enzyme kinetics studies and comparison with human orthologs.

Main Results:

• Loss of AdSS function led to adenine auxotrophy and complete loss of virulence in C. neoformans.
• The crystal structure of Cryptococcal AdSS was determined, representing the first fungal AdSS structure.
• Species-specific differences between fungal and human AdSS were identified, crucial for targeted drug development.
• Enzyme kinetic data provided insights into enzyme function and potential inhibition mechanisms.

Conclusions:

• Adenylosuccinate synthetase (AdSS) is a validated and promising antifungal drug target.
• Structural and kinetic data facilitate the rational design of novel antifungal compounds targeting fungal AdSS.
• This research provides a foundation for developing new therapies against Cryptococcus neoformans infections.